Needham & Company maintains a 'Buy' on NPS Pharmaceuticals Inc. (NASDAQ: NPSP).

Needham analyst says, "NPS initiated the Gattex NDA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE